Form 8-K - Current report:
SEC Accession No. 0001140361-26-016834
Filing Date
2026-04-27
Accepted
2026-04-27 07:08:41
Documents
44
Period of Report
2026-04-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20071554_8k.htm   iXBRL 8-K 26269
2 EXHIBIT 99.1 ef20071554_ex99-1.htm EX-99.1 70342
6 ef20071554_ex99-1slide1.jpg GRAPHIC 77918
7 ef20071554_ex99-1slide2.jpg GRAPHIC 442494
8 ef20071554_ex99-1slide3.jpg GRAPHIC 149493
9 ef20071554_ex99-1slide4.jpg GRAPHIC 485165
10 ef20071554_ex99-1slide5.jpg GRAPHIC 150876
11 ef20071554_ex99-1slide6.jpg GRAPHIC 176261
12 ef20071554_ex99-1slide7.jpg GRAPHIC 140882
13 ef20071554_ex99-1slide8.jpg GRAPHIC 176275
14 ef20071554_ex99-1slide9.jpg GRAPHIC 178147
15 ef20071554_ex99-1slide10.jpg GRAPHIC 151593
16 ef20071554_ex99-1slide11.jpg GRAPHIC 98075
17 ef20071554_ex99-1slide12.jpg GRAPHIC 74628
18 ef20071554_ex99-1slide13.jpg GRAPHIC 142265
19 ef20071554_ex99-1slide14.jpg GRAPHIC 172225
20 ef20071554_ex99-1slide15.jpg GRAPHIC 116354
21 ef20071554_ex99-1slide16.jpg GRAPHIC 90458
22 ef20071554_ex99-1slide17.jpg GRAPHIC 80838
23 ef20071554_ex99-1slide18.jpg GRAPHIC 103178
24 ef20071554_ex99-1slide19.jpg GRAPHIC 147946
25 ef20071554_ex99-1slide20.jpg GRAPHIC 156890
26 ef20071554_ex99-1slide21.jpg GRAPHIC 142711
27 ef20071554_ex99-1slide22.jpg GRAPHIC 98059
28 ef20071554_ex99-1slide23.jpg GRAPHIC 74594
29 ef20071554_ex99-1slide24.jpg GRAPHIC 184683
30 ef20071554_ex99-1slide25.jpg GRAPHIC 235879
31 ef20071554_ex99-1slide26.jpg GRAPHIC 158821
32 ef20071554_ex99-1slide27.jpg GRAPHIC 132149
33 ef20071554_ex99-1slide28.jpg GRAPHIC 146380
34 ef20071554_ex99-1slide29.jpg GRAPHIC 172916
35 ef20071554_ex99-1slide30.jpg GRAPHIC 79253
36 ef20071554_ex99-1slide31.jpg GRAPHIC 189559
37 ef20071554_ex99-1slide32.jpg GRAPHIC 205056
  Complete submission text file 0001140361-26-016834.txt   7315474

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA grce-20260427.xsd EX-101.SCH 3859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE grce-20260427_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grce-20260427_pre.xml EX-101.PRE 16040
47 EXTRACTED XBRL INSTANCE DOCUMENT ef20071554_8k_htm.xml XML 4232
Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-322-1602
Grace Therapeutics, Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-35776 | Film No.: 26896479
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)